The SLC12A3 gene plays a crucial role in the proper function of the kidneys, specifically in the reabsorption of sodium chloride in the distal convoluted tubule. Mutations in this gene can lead to a rare condition known as Gitelman syndrome, which is often mistakenly referred to as a form of Bartter syndrome due to their clinical similarities. However, it's important to note that Gitelman syndrome is distinct from Bartter syndrome, with the latter involving different genes.
Gitelman syndrome is characterized by a range of symptoms, including salt craving, fatigue, muscle weakness, and spasms, due to an imbalance of minerals and electrolytes in the body. It's a condition that typically manifests in late childhood or adulthood.
For individuals suspected of having Gitelman syndrome, genetic testing of the SLC12A3 gene can provide a definitive diagnosis. In the UAE, DNA Labs offers this specific genetic test, which is a crucial step in confirming the diagnosis and enabling appropriate management and treatment of the condition. The cost of the SLC12A3 gene test at DNA Labs UAE is 4400 AED.
This genetic test involves analyzing the DNA to identify mutations in the SLC12A3 gene that are known to cause Gitelman syndrome. A positive result can help in the formulation of a treatment plan that may include nutritional supplements and medications to manage symptoms and prevent complications. It's also valuable for genetic counseling, offering families insight into the inheritance pattern and the risk of passing the condition to future generations.
The SLC12A5 Gene Bartter Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the SLC12A5 gene, which are linked to a specific form of Bartter syndrome. Bartter syndrome is a group of rare inherited disorders that affect the kidneys, leading to imbalances in electrolytes, such as potassium, chloride, and sodium. These imbalances can result in a variety of symptoms, including frequent urination, thirst, muscle weakness, and growth delays.
This genetic test is crucial for individuals suspected of having this condition or for families with a history of Bartter syndrome, as it provides definitive information regarding the genetic underpinnings of the disorder. Early diagnosis through genetic testing can facilitate timely intervention and management strategies to mitigate symptoms and improve quality of life.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics and research. DNA Labs UAE employs cutting-edge technology and methodologies to ensure accurate and reliable results. The cost of the SLC12A5 Gene Bartter Syndrome Genetic Test is 4400 AED, reflecting the specialized nature of the test and the sophisticated resources required to perform it.
For patients and families facing the challenges of Bartter syndrome, this genetic test represents a critical step towards understanding their condition and navigating the path to effective treatment and management.
The SLC12A7 gene plays a critical role in the proper functioning of the kidneys, particularly in the regulation of electrolyte and fluid balance. Mutations in this gene can lead to a rare condition known as Bartter syndrome, which is characterized by a set of symptoms including salt wasting, hypokalemic metabolic alkalosis, hypercalciuria, and elevated renin and aldosterone levels. This condition often presents in infancy or childhood with symptoms such as dehydration, frequent urination, and growth retardation.
To diagnose Bartter syndrome and specifically identify mutations in the SLC12A7 gene, a genetic test is available at DNA Labs UAE. This test involves analyzing the patient's DNA to look for mutations in the SLC12A7 gene that are known to cause the condition. The test is crucial for confirming the diagnosis of Bartter syndrome, which can then guide treatment and management strategies to mitigate symptoms and prevent complications.
The cost of the SLC12A7 Gene Bartter Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art laboratory setting by experienced geneticists and technicians, ensuring accurate and reliable results. The test not only aids in the diagnosis of Bartter syndrome but also helps in the assessment of the risk of passing the condition to future generations, making it an invaluable tool for affected families.
The SLC12A1 gene plays a crucial role in the body's ability to manage electrolyte balance and blood pressure. Mutations in this gene can lead to Bartter Syndrome Type 1, a rare inherited condition characterized by kidney dysfunction, frequent urination, thirst, and electrolyte imbalances from an early age. Bartter Syndrome Type 1 can have significant health implications if not diagnosed and managed properly.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the SLC12A1 gene, helping in the diagnosis of Bartter Syndrome Type 1. This test is crucial for individuals showing symptoms of the syndrome or those with a family history of the condition, as it can provide a definitive diagnosis, allowing for appropriate management and treatment plans to be established.
The test costs 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the SLC12A1 gene. The results from this test can guide healthcare providers in creating a tailored treatment plan that may include nutritional support, medications, and regular monitoring of electrolyte levels and kidney function.
By offering this genetic test, DNA Labs UAE plays a vital role in the early detection and management of Bartter Syndrome Type 1, ultimately improving the quality of life for affected individuals.
The KCNJ1 gene Bartter Syndrome Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the KCNJ1 gene. This gene is crucial for the proper function of kidney cells involved in electrolyte and fluid balance. Mutations in the KCNJ1 gene are directly linked to Bartter Syndrome Type 2, a rare inherited condition that affects the kidney's ability to reabsorb sodium, leading to imbalances in electrolytes and various clinical symptoms such as dehydration, frequent urination, and growth retardation.
The test is conducted using a sample of the patient's blood or saliva, through which DNA is extracted and analyzed for specific mutations in the KCNJ1 gene. This genetic test is pivotal for the early diagnosis and management of Bartter Syndrome Type 2, allowing for tailored treatment plans that can mitigate symptoms and improve the quality of life for affected individuals.
The cost of the KCNJ1 gene Bartter Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This investment in health care is essential for families with a history of the syndrome or those exhibiting symptoms, providing them with crucial information for managing the condition.
The STIM1 gene plays a crucial role in the regulation of calcium levels within cells, which is vital for various cellular functions. Mutations in the STIM1 gene can lead to Stormorken syndrome, a rare genetic disorder characterized by a spectrum of symptoms including thrombocytopenia (a condition involving low platelet counts), asplenia (absence of the spleen), severe muscle weakness, short stature, and other anomalies.
To diagnose this complex condition, genetic testing of the STIM1 gene is essential. DNA Labs UAE offers a specialized genetic test for Stormorken syndrome, targeting the STIM1 gene to identify mutations that may cause the disorder. This test is crucial for accurate diagnosis, which can then guide appropriate treatment and management strategies for affected individuals.
The cost of the STIM1 gene test for Stormorken syndrome at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect the genetic variations linked to the syndrome, providing essential information for patients and their families. Given the complexity of the condition and the tailored medical care needed by those affected, the test represents a critical step towards understanding and managing Stormorken syndrome.
The ELN gene supravalvar aortic stenosis genetic test is a specialized diagnostic tool used to detect mutations in the ELN gene, which are known to cause supravalvar aortic stenosis (SVAS). SVAS is a congenital heart defect characterized by the narrowing of the aorta, the major artery carrying blood from the heart to the rest of the body. This condition can lead to various cardiovascular complications if not diagnosed and managed properly. The ELN gene plays a crucial role in the production of elastin, a protein that provides elasticity and strength to the arterial walls. Mutations in this gene can disrupt normal elastin production, leading to the development of SVAS.
This genetic test is performed at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED. The procedure involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the ELN gene. The results from this test can provide valuable information for the diagnosis, management, and genetic counseling of individuals and families affected by supravalvar aortic stenosis. It is particularly important for early detection and intervention, which can significantly improve the quality of life and prognosis for those with the condition.
The F2 Gene Thrombophilia Due to Thrombin Defect Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the F2 gene, which codes for prothrombin (also known as thrombin). Thrombin is a crucial enzyme in the blood coagulation process, and mutations in the F2 gene can lead to an increased risk of developing thrombophilia. Thrombophilia is a disorder characterized by an elevated tendency to form abnormal blood clots that can block blood vessels, posing serious health risks such as deep vein thrombosis (DVT), pulmonary embolism, and even stroke.
This test is particularly important for individuals with a family history of thrombophilia or those who have experienced unexplained thrombotic events, as it can help in the early detection and management of the condition. The process involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific genetic variations associated with the disorder.
At DNA Labs UAE, the cost for the F2 Gene Thrombophilia Due to Thrombin Defect Genetic Test is set at 4400 AED. The test is conducted with high precision and accuracy, providing crucial information that can guide healthcare providers in tailoring prevention and treatment strategies for affected individuals, ultimately helping to reduce the risk of serious thrombotic events.
The "MED13L Gene Transposition of the Great Arteries Dextro-Looped 1 Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the MED13L gene, which are associated with congenital heart defects, specifically Transposition of the Great Arteries Dextro-Looped 1 (dTGA). This condition involves an abnormal arrangement of the two main arteries leaving the heart, which can significantly impact blood flow and oxygen delivery throughout the body. The test is crucial for early diagnosis and management of the condition, potentially guiding treatment decisions and informing family planning.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test utilizes advanced genomic technologies to accurately detect alterations in the MED13L gene. The cost of the test is set at 4400 AED, reflecting the sophisticated methods and expertise involved in conducting the analysis and interpreting the results. This test is particularly valuable for families with a history of congenital heart defects or for individuals showing symptoms related to dTGA, offering them a crucial insight into their genetic makeup and its implications on their health.
The CALCRL gene plays a crucial role in the proper development and function of the vascular system. Mutations or deficiencies in the CALCRL gene can lead to a variety of vascular system defects, impacting blood flow and potentially leading to severe health issues. Recognizing the importance of early detection and management of CALCRL-related conditions, DNA Labs UAE offers a specialized genetic test designed to identify deficiencies in the CALCRL gene.
This genetic test is a vital tool for individuals with a family history of vascular system defects or those who have symptoms suggesting a potential CALCRL gene deficiency. By analyzing a sample of the patient's DNA, the test can confirm whether there are mutations in the CALCRL gene that could contribute to vascular system abnormalities.
The cost of the CALCRL deficiency genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately assess the presence of CALCRL gene mutations. Given the complexity of genetic testing and the specialized analysis involved, the price reflects the meticulous process necessary to provide reliable results.
Undergoing this test at DNA Labs UAE ensures access to leading-edge genetic testing technology, expert analysis, and the potential to significantly impact patient care by guiding treatment decisions and preventive measures for those affected by or at risk of CALCRL-related vascular system defects.
